DALLAS, Jan. 10, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a $100,000 wholesale order of its new Hemp4mula CBD Infused Gummies. The wholesale buyer recently ordered $100,000 of KALY’s Hemp4mula CBD Infused Chewing Gum. The wholesale buyer plans to have both the Hemp4mula CBD Infused Chewing Gum and Gummies available for sale at select retail drugstore locations and through the soon to be launched USMJ E-commerce Site from North American Cannabis Holdings, Inc. (USOTC: USMJ).
In December, Kali-Extracts announced launching its own line of hemp-derived CBD infused candies and vapes under the brand name Hemp4mula. Kali-Extracts Hemp4mula CBD Infused Chewing Gum will come in a blister back of 8 pieces with 10 mg each of hemp-derived CBD. Kali-Extracts Hemp4mula CBD Infused Gummies will come in a container of 30 pieces with 10 mg each of hemp-derived CBD. Kali-Extracts expects to soon produce hemp-derived CBD infused mints in addition the chewing gum and gummies. Hemp4mula vapes are anticipated to also soon be in production.
KALY recently acquired a biotech company with a patented cannabis extraction process. Accordingly, KALY updated its overall business plan (a presentation on the company’s updated business plan is available on KALY’s website). Hemp4mula is part of the updated business plan which management is rapidly executing. The company recently announced a $300,000 hemp-derived CBD extraction contract with Puration, Inc. The CBD Kali-extracts will produce is to support PURA’s contract to produce a private labeled CBD infused Water for Generex Biotechnology.
Goldman Small Cap Research Report published an analyst research report on KALY this past Tuesday, January 8th, 2019 that highlights KALY’s cannabis pharmaceutical value. The report is available under “research” on the OTCMarkets website. The research report is the first report from Goldman Small Cap Research as part of an ongoing research engagement. The report outlines the company’s current positioning and potential, upcoming milestones. The report is intended to augment the current information available on the OTCMarkets website. The report is also available to read or download, along with associated disclosures and disclaimers, at www.GoldmanResearch.com.
To learn more about the company visit https://www.kali-extracts.com/
Check back frequently to the company’s website and to the OTCMarkets website for more updates coming soon as management populates the new company website with additional information and brings all corporate information current on the OTCMarkets website.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company’s actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.